Exane Derivatives’s C.H. Robinson CHRW Stock Holding History

Exane Derivatives’s Portfolio CHRW Stock Details CHRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.82K	Hold	18	–	–	﹤0.01%	449
2022 Q1	$1.94K	Sell	18 -8,298	-100%	-$843K	﹤0.01%	756
2021 Q4	$895K	Buy	8,316 +4,110	+98%	+$399K	0.22%	103
2021 Q3	$366K	Sell	4,206 -375	-8%	-$33.9K	0.09%	242
2021 Q2	$424K	Sell	4,581 -1,737	-27%	-$169K	0.1%	220
2021 Q1	$603K	Buy	+6,318	New	+$590K	0.17%	129
2016 Q2	–	Sell	-189,454	Closed	-$14.1M	–	568
2016 Q1	$14.1M	Sell	189,454 -88,394	-32%	-$6.07M	1.87%	20
2015 Q4	$17.2M	Buy	277,848 +9,607	+4%	+$647K	2.36%	17
2015 Q3	$18.2M	Buy	+268,241	New	+$18M	2.3%	16
2015 Q1	–	Sell	-172,819	Closed	-$12.9M	–	525
2014 Q4	$12.9M	Buy	+172,819	New	+$12.3M	1.79%	20

Other funds holding CHRW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exane Derivatives's CHRW Position: Q2 2022 in Review

Exane Derivatives held its C.H. Robinson (CHRW) position steady in Q2 2022 at 18 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

Exane Derivatives first reported a position in CHRW in Q4 2014 and has held it in 10 quarters since. The position peaked at $18.2M in Q3 2015. 648 funds tracked by Wall St. Rank hold CHRW as of Q2 2022.

Exane Derivatives held 18 shares of C.H. Robinson worth $1.82K as of Q2 2022.
Exane Derivatives left its C.H. Robinson share count unchanged in Q2 2022.
C.H. Robinson made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #449 holding.
Exane Derivatives first reported a position in C.H. Robinson in Q4 2014 and has held it in 10 quarters since.
Exane Derivatives's C.H. Robinson position peaked at $18.2M in Q3 2015.
648 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.